PFM Health Sciences, LP — 13F Holdings & Portfolio
CIK 1442756 · latest 13F-HR filed 2026-08-14
PFM Health Sciences, LP manages $1.17B in 13F-reported U.S. long-equity assets across 98 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are ASND (5.34%), AXSM (4.61%), LLY (4.04%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 33 new positions and exited 14; 40 existing positions rose in reported value and 20 fell.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
Long-equity book
Distinct positions
Filed 2026-08-14
vs 2026-03-31
Portfolio charts
Latest quarter's book, what changed, and how the portfolio has evolved across filings.
Portfolio map
Q2 26Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.
Sector mix
% of 13F valueSectors from each company's SIC code; funds and ETFs grouped separately.
Biggest buys and sells
Q1 26 → Q2 26Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.
13F assets and positions
4 quartersTotal reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.
Top positions over time
reported valueThe eight largest current positions, valued at each quarter end.
Concentration
top 10 = 34.3%Cumulative share of the portfolio held in the largest N positions.
As of the firm’s regulatory filing dated Mar 31, 2026.
SUITE 2650
SAN FRANCISCO, CA 94111
| Name | Title / Status | Ownership | Type |
|---|---|---|---|
| ALJOE, JONATHAN, JUDE Control | CHIEF FINANCIAL OFFICER since Jun 2023 | Less than 5% | Individual |
| GROSSMAN, BRIAN, DAVID Control | LIMITED PARTNER, PORTFOLIO MANAGER since Feb 2008 | 75% or more | Individual |
| MOONEY, DARREN, WILLIAM Control | GENERAL COUNSEL AND CHIEF COMPLIANCE OFFICER since May 2023 | Less than 5% | Individual |
| PFM HEALTH SCIENCES GP LLC Control | GENERAL PARTNER since Oct 2020 | Less than 5% | Domestic Entity |
| GROSSMAN, BRIAN, DAVID Control Indirect owner via PFM HEALTH SCIENCES GP LLC | MANAGING MEMBER since Oct 2020 | 75% or more | Individual |
Ownership & leadership changes · 13 filings with changes since Mar 30, 2012
From the firm’s regulatory filings, newest first. Dates are filing dates: a filing that no longer lists someone does not say when they left.
- ChangedMOONEY, DARREN, WILLIAM · title CHIEF COMPLIANCE OFFICER AND COUNSEL → GENERAL COUNSEL AND CHIEF COMPLIANCE OFFICER
- ChangedMOONEY, DARREN, WILLIAM · title CHIEF COMPLIANCE OFFICER → CHIEF COMPLIANCE OFFICER AND COUNSEL
- No longer listedDUBORD, YUAN, SHI · LIMITED PARTNER, CFO · Less than 5% · control person · listed since Jul 2014
- No longer listedSADOW, DARIN, SCOTT · LIMITED PARTNER, GENERAL COUNSEL, CCO · Less than 5% · control person · listed since Mar 2011
- AddedALJOE, JONATHAN, JUDE · CHIEF FINANCIAL OFFICER · Less than 5% · control person
- AddedMOONEY, DARREN, WILLIAM · CHIEF COMPLIANCE OFFICER · Less than 5% · control person
- No longer listedGROSSMAN, BRIAN, DAVID · M/M · 50–75% · indirect via PARTNER FUND MANAGEMENT GP, LLC · control person · listed since Jan 2016
- No longer listedJAMES, CHRISTOPHER, MEDLOCK · LIMITED PARTNER, PORTFOLIO MANAGER, CO-MANAGING PARTNER · 50–75% · control person · listed since Feb 2008
- No longer listedJAMES, CHRISTOPHER, MEDLOCK · M/M · 50–75% · indirect via PARTNER FUND MANAGEMENT GP, LLC · control person · listed since Feb 2008
- No longer listedPARTNER FUND MANAGEMENT GP, LLC · GENERAL PARTNER, PARTNER FUND MANAGEMENT, L.P. · Less than 5% · control person · listed since Feb 2008
- AddedGROSSMAN, BRIAN, DAVID · MANAGING MEMBER · 75% or more · indirect via PFM HEALTH SCIENCES GP LLC · control person
- AddedPFM HEALTH SCIENCES GP LLC · GENERAL PARTNER · Less than 5% · control person
- ChangedGROSSMAN, BRIAN, DAVID · title LIMITED PARTNER, PORTFOLIO MANAGER, CO-MANAGING PARTNER → LIMITED PARTNER, PORTFOLIO MANAGER; ownership 50–75% → 75% or more
- No longer listedGOODELL, WILLIAM, RICE · LIMITED PARTNER, PRESIDENT, COO · Less than 5% · control person · listed since Jun 2015
- No longer listedGROSSMAN, BRIAN, DAVID · M/M · 50–75% · indirect via PARTNER FUND MANAGEMENT GP, L.P.; PARTNER INVESTMENT MANAGEMENT GP, LLC; PARTNER ADVISORY SERVICES GP, LLC · control person · listed since Jan 2016
- No longer listedJAMES, CHRISTOPHER, MEDLOCK · M/M · 50–75% · indirect via PARTNER FUND MANAGEMENT GP, L.P.; PARTNER INVESTMENT MANAGEMENT GP, LLC; PARTNER ADVISORY SERVICES GP, LLC · control person · listed since Feb 2008
- No longer listedPARTNER ADVISORY SERVICES GP, LLC · GENERAL PARTNER, PARTNER ADVISORY SERVICES, L.P. · Less than 5% · control person · listed since Feb 2008
- No longer listedPARTNER INVESTMENT MANAGEMENT GP, LLC · GENERAL PARTNER, PARTNER INVESTMENT MANAGEMENT, L.P. · Less than 5% · control person · listed since Feb 2008
- AddedGROSSMAN, BRIAN, DAVID · M/M · 50–75% · indirect via PARTNER FUND MANAGEMENT GP, LLC · control person
- AddedJAMES, CHRISTOPHER, MEDLOCK · M/M · 50–75% · indirect via PARTNER FUND MANAGEMENT GP, LLC · control person
- AddedGROSSMAN, BRIAN, DAVID · M/M · 50–75% · indirect via PARTNER FUND MANAGEMENT GP, L.P.; PARTNER INVESTMENT MANAGEMENT GP, LLC; PARTNER ADVISORY SERVICES GP, LLC · control person
- ChangedGROSSMAN, BRIAN, DAVID · title LIMITED PARTNER, PORTFOLIO MANAGER → LIMITED PARTNER, PORTFOLIO MANAGER, CO-MANAGING PARTNER; ownership 10–25% → 50–75%
- ChangedJAMES, CHRISTOPHER, MEDLOCK · title LIMITED PARTNER, CIO, PORTFOLIO MANAGER → LIMITED PARTNER, PORTFOLIO MANAGER, CO-MANAGING PARTNER
- ChangedJAMES, CHRISTOPHER, MEDLOCK · indirect via PARTNER FUND MANAGEMENT GP, L.P.; PARTNER INVESTMENT MANAGEMENT GP, LLC; PARTNER ADVISORY SERVICES GP, LLC: ownership 75% or more → 50–75%
- ChangedSADOW, DARIN, SCOTT · title LIMITED PARTNER, CCO → LIMITED PARTNER, GENERAL COUNSEL, CCO
- ChangedGOODELL, WILLIAM, RICE · title LIMITED PARTNER, COO → LIMITED PARTNER, PRESIDENT, COO
- AddedGOODELL, WILLIAM, RICE · LIMITED PARTNER, COO · Less than 5% · control person
- ChangedGROSSMAN, BRIAN, DAVID · now a control person
- ChangedSADOW, DARIN, SCOTT · now a control person
- No longer listedSEGURITAN, FREDERICK, ANTHONY · LIMITED PARTNER · 5–10% · listed since Feb 2008
- No longer listedSUMME, KIMBERLY, ANNE · LIMITED PARTNER, COO, GENERAL COUNSEL · Less than 5% · listed since Jan 2011
Older changes (4 more filings)
- No longer listedMOORE, ERIC, TODD · LIMITED PARTNER, CFO · Less than 5% · control person · listed since Feb 2008
- AddedDUBORD, YUAN, SHI · LIMITED PARTNER, CFO · Less than 5% · control person
- ChangedSADOW, DARIN, SCOTT · title CCO → LIMITED PARTNER, CCO
- No longer listedARISTIDES, CHRISTOPHER, GEORGE · LIMITED PARTNER, PORTFOLIO MANAGER · 10–25% · listed since Feb 2008
- No longer listedBOUSABA, JOSEPH, NICOLAS · LIMITED PARTNER · 5–10% · listed since Feb 2008
- No longer listedTARANTINO, KENN, RICHARD · LIMITED PARTNER · 5–10% · listed since Feb 2008
- ChangedJAMES, CHRISTOPHER, MEDLOCK · ownership 25–50% → 50–75%
- ListedARISTIDES, CHRISTOPHER, GEORGE · LIMITED PARTNER, PORTFOLIO MANAGER · 10–25%
- ListedBOUSABA, JOSEPH, NICOLAS · LIMITED PARTNER · 5–10%
- ListedGROSSMAN, BRIAN, DAVID · LIMITED PARTNER, PORTFOLIO MANAGER · 10–25%
- ListedJAMES, CHRISTOPHER, MEDLOCK · LIMITED PARTNER, CIO, PORTFOLIO MANAGER · 25–50% · control person
- ListedJAMES, CHRISTOPHER, MEDLOCK · M/M · 75% or more · indirect via PARTNER FUND MANAGEMENT GP, L.P.; PARTNER INVESTMENT MANAGEMENT GP, LLC; PARTNER ADVISORY SERVICES GP, LLC · control person
- ListedMOORE, ERIC, TODD · LIMITED PARTNER, CFO · Less than 5% · control person
- ListedPARTNER ADVISORY SERVICES GP, LLC · GENERAL PARTNER, PARTNER ADVISORY SERVICES, L.P. · Less than 5% · control person
- ListedPARTNER FUND MANAGEMENT GP, LLC · GENERAL PARTNER, PARTNER FUND MANAGEMENT, L.P. · Less than 5% · control person
- ListedPARTNER INVESTMENT MANAGEMENT GP, LLC · GENERAL PARTNER, PARTNER INVESTMENT MANAGEMENT, L.P. · Less than 5% · control person
- ListedSADOW, DARIN, SCOTT · CCO · Less than 5%
- ListedSEGURITAN, FREDERICK, ANTHONY · LIMITED PARTNER · 5–10%
- ListedSUMME, KIMBERLY, ANNE · LIMITED PARTNER, COO, GENERAL COUNSEL · Less than 5%
- ListedTARANTINO, KENN, RICHARD · LIMITED PARTNER · 5–10%
Quarter-over-quarter changes
Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.
Top Adds (vs prior quarter)
- UNITEDHEALTH GROUP INC$21.0M +133.6%
- ICON PUB LTD CO$17.3M +272.6%
- REVOLUTION MEDICINES INC$13.1M +95.9%
- STRYKER CORPORATION$10.6M +147.2%
- WATERS CORP$10.6M +89.5%
Top Trims
- TENET HEALTHCARE CORP-$51.5M -68.5%
- PENUMBRA INC-$26.9M -58.6%
- ELI LILLY & CO-$13.4M -22.2%
- ABBOTT LABORATORIES-$7.0M -48.2%
- NATERA INC-$6.0M -50.1%
New Positions
- ASCENDIS PHARMA A/S$62.2M
- HUMANA INC$37.5M
- METTLER TOLEDO INTERNATIONAL$17.0M
- MERCK & CO INC$16.3M
- CYTOKINETICS INC$16.3M
Exited Positions
- ASCENDIS PHARMA A/S$34.8M
- GLAUKOS CORP$23.2M
- CENTESSA PHARMACEUTICALS PLC$21.0M
- ASCENDIS PHARMA A/S$16.9M
- NEOGENOMICS INC$13.2M
PFM Health Sciences, LP Holdings (2026-06-30)
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | ASCENDIS PHARMA A/S | ASND | K08588103 | $62.2M | 5.34% | 233,171 | SH |
| 2 | AXSOME THERAPEUTICS INC. | AXSM | 05464T104 | $53.8M | 4.61% | 219,596 | SH |
| 3 | ELI LILLY & CO | LLY | 532457108 | $47.1M | 4.04% | 39,258 | SH |
| 4 | JAZZ PHARMACEUTICALS PLC | JAZZ | G50871105 | $38.7M | 3.32% | 160,768 | SH |
| 5 | HUMANA INC | HUM | 444859102 | $37.5M | 3.22% | 94,375 | SH |
| 6 | UNITEDHEALTH GROUP INC | UNH | 91324P102 | $36.7M | 3.15% | 88,276 | SH |
| 7 | NEUROCRINE BIOSCIENCES INC | NBIX | 64125C109 | $36.0M | 3.09% | 213,407 | SH |
| 8 | INHIBRX BIOSCIENCES INC | INBX | 45720N103 | $29.2M | 2.51% | 308,385 | SH |
| 9 | UNITED THERAPEUTICS CORP DEL | UTHR | 91307C102 | $27.1M | 2.32% | 49,991 | SH |
| 10 | REVOLUTION MEDICINES INC | RVMD | 76155X100 | $26.8M | 2.30% | 143,222 | SH |
| 11 | ICON PUB LTD CO | ICLR | G4705A100 | $23.7M | 2.03% | 136,482 | SH |
| 12 | TENET HEALTHCARE CORP | THC | 88033G407 | $23.7M | 2.03% | 126,572 | SH |
| 13 | EDWARDS LIFESCIENCES CORP | EW | 28176E108 | $22.7M | 1.94% | 250,453 | SH |
| 14 | WATERS CORP | WAT | 941848103 | $22.4M | 1.93% | 59,825 | SH |
| 15 | PENUMBRA INC | PEN | 70975L107 | $19.0M | 1.63% | 60,221 | SH |
| 16 | BRIDGEBIO PHARMA INC | BBIO | 10806X102 | $18.9M | 1.62% | 253,358 | SH |
| 17 | STRYKER CORPORATION | SYK | 863667101 | $17.8M | 1.53% | 56,637 | SH |
| 18 | METTLER TOLEDO INTERNATIONAL | MTD | 592688105 | $17.0M | 1.46% | 13,344 | SH |
| 19 | INDIVIOR PHARMACEUTICALS INC | SUPN | 45579U109 | $16.5M | 1.41% | 401,208 | SH |
| 20 | MERCK & CO INC | MRK | 58933Y105 | $16.3M | 1.40% | 127,118 | SH |
| 21 | CYTOKINETICS INC | CYTK | 23282W605 | $16.3M | 1.40% | 191,686 | SH |
| 22 | LANTHEUS HLDGS INC | LNTH | 516544103 | $16.2M | 1.39% | 146,403 | SH |
| 23 | CENTENE CORP DEL | CNC | 15135B101 | $16.0M | 1.37% | 248,867 | SH |
| 24 | COOPER COS INC | COO | 216648501 | $15.8M | 1.36% | 220,890 | SH |
| 25 | MADRIGAL PHARMACEUTICALS INC | MDGL | 558868105 | $15.7M | 1.35% | 29,313 | SH |
| 26 | ACADIA HEALTHCARE COMPANY IN | ACHC | 00404A109 | $15.5M | 1.33% | 524,934 | SH |
| 27 | ORUKA THERAPEUTICS INC | ORKA | 687604108 | $15.1M | 1.30% | 158,825 | SH |
| 28 | OSCAR HEALTH INC | OSCR | 687793109 | $14.8M | 1.27% | 519,016 | SH |
| 29 | THERMO FISHER SCIENTIFIC INC | TMO | 883556102 | $14.3M | 1.23% | 28,496 | SH |
| 30 | CVS HEALTH CORP | CVS | 126650100 | $14.2M | 1.22% | 137,457 | SH |
| 31 | MERIT MED SYS INC | MMSI | 589889104 | $13.7M | 1.17% | 197,038 | SH |
| 32 | PRAXIS PRECISION MEDICINES I | PRAX | 74006W207 | $12.9M | 1.11% | 38,575 | SH |
| 33 | CELLDEX THERAPEUTICS INC NEW | CLDX | 15117B202 | $12.8M | 1.09% | 342,751 | SH |
| 34 | NOVO-NORDISK A S | NVO | 670100205 | $12.7M | 1.09% | 265,016 | SH |
| 35 | INTEGER HLDGS CORP | ITGR | 45826H109 | $11.8M | 1.02% | 126,669 | SH |
| 36 | DIANTHUS THERAPEUTICS INC | DNTH | 252828108 | $11.8M | 1.01% | 121,222 | SH |
| 37 | DEFINIUM THERAPEUTICS INC | DFTX | 24477V105 | $11.7M | 1.01% | 249,020 | SH |
| 38 | GILEAD SCIENCES INC | GILD | 375558103 | $11.5M | 0.98% | 90,858 | SH |
| 39 | RHYTHM PHARMACEUTICALS INC | RYTM | 76243J105 | $11.3M | 0.97% | 101,550 | SH |
| 40 | SCHEIN HENRY INC | HSIC | 806407102 | $11.2M | 0.96% | 134,423 | SH |
| 41 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 04280A100 | $10.7M | 0.92% | 131,667 | SH |
| 42 | TANGO THERAPEUTICS INC | TNGX | 87583X109 | $10.2M | 0.87% | 326,047 | SH |
| 43 | TELEFLEX INCORPORATED | TFX | 879369106 | $10.1M | 0.87% | 79,708 | SH |
| 44 | VIKING THERAPEUTICS INC | VKTX | 92686J106 | $10.0M | 0.85% | 255,330 | SH |
| 45 | BRIGHTSPRING HEALTH SVCS INC | BTSG | 10950A106 | $9.9M | 0.85% | 141,914 | SH |
| 46 | VERA THERAPEUTICS INC | VERA | 92337R101 | $9.6M | 0.83% | 224,289 | SH |
| 47 | ROIVANT SCIENCES LTD | ROIV | G76279101 | $9.5M | 0.81% | 268,008 | SH |
| 48 | CG ONCOLOGY INC | CGON | 156944100 | $9.1M | 0.78% | 128,286 | SH |
| 49 | AMNEAL PHARMACEUTICALS INC | AMRX | 03168L105 | $8.3M | 0.71% | 480,715 | SH |
| 50 | EUPRAXIA PHARMACEUTICALS INC | EPRX | 29842P105 | $8.0M | 0.69% | 1,210,661 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | $1.17B | 98 | 0001442756-26-000006 |
| 2026-03-31 | 2026-05-15 | $1.10B | 83 | 0001442756-26-000002 |
| 2025-12-31 | 2026-02-17 | $1.00B | 78 | 0001442756-26-000001 |
| 2025-09-30 | 2025-11-14 | $1.30B | 72 | 0001442756-25-000007 |
SUITE 2650
SAN FRANCISCO, CA 94111